SCHEMBL6459850

SCHEMBL6459850

Cc1cc(OCCCCO)cc(C)c1N

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 4/20 0.47
MAPK1 P28482 1/20 0.47
TSHR P16473 3/20 0.44
ALOX15 P16050 1/20 0.44
CYP1A2 P05177 1/20 0.44
POLB P06746 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C19 P33261 1/20 0.44
PDIA6 Q15084 1/20 0.41
GAA P10253 1/20 0.41
LMNA P02545 1/20 0.39
MCL1 Q07820 2/20 0.39
XDH P47989 1/20 0.38
ALDH1A1 P00352 1/20 0.38
CYP3A4 P08684 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
THRA P10827 1/20 0.37
THRB P10828 1/20 0.37
IKBKB O14920 1/20 0.36
PLA2G2A P14555 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25231418 0.94 TP53 (0.45) TP53MAPK1TSHRALOX15CYP1A2
SCHEMBL11706025 0.88 TP53 (0.46) TP53MAPK1TSHRALOX15CYP1A2
SCHEMBL22911173 0.84 TP53 (0.40) TP53MAPK1TSHRALOX15CYP1A2
SCHEMBL6460166 0.82 TSHR (0.51) TP53TSHRALOX15PDIA6GAA
SCHEMBL7220329 0.81 TSHR (0.54) TP53TSHRALOX15PDIA6GAA
SCHEMBL19480454 0.81 TSHR (0.54) TP53TSHRALOX15PDIA6GAA
SCHEMBL10282187 0.80 PDIA6 (0.49) TP53MAPK1TSHRPDIA6GAA
SCHEMBL7225914 0.80 TSHR (0.44) TP53TSHRCYP1A2CYP2D6CYP2C19
SCHEMBL7516991 0.79 TSHR (0.42) TP53MAPK1TSHRALOX15CYP1A2
SCHEMBL6459837 0.79 THRB (0.46) TP53MAPK1TSHRALOX15CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1495034-A2 MIMICS OF ACYL COENZYME-A COMPRISING PANTOLACTONE AND PANTOTHENIC ACID DERIVATIVES, COMPOSITIONS THEREOF, AND METHODS OF CHOLESTEROL MANAGEMENT AND RELATED USES Esperion Therapeutics, Inc. (US) 2005-01-12 EP disclosed
US-20030236213-A1 Mimics of acyl coenzyme-A comprising pantolactone and pantothenic acid derivatives, compositions thereof, and methods of cholesterol management and related uses ESPERION THERAPEUTICS 2003-12-25 US disclosed
WO-2003087040-A2 MIMICS OF ACYL COENZYME-A COMPRISING PANTOLACTONE AND PANTOTHENIC ACID DERIVATIVES, COMPOSITIONS THEREOF, AND METHODS OF CHOLESTEROL MANAGEMENT AND RELATED USES ESPERION THERAPEUTICS, INC. (US) 2003-10-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030236213-A1 Mimics of acyl coenzyme-A comprising pantolactone and pantothenic acid derivatives, compositions thereof, and methods of cholesterol management and related uses COASY, HMGCR, ACACA TP53 791/4885MAPK1 1852/4885TSHR 2733/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.